Blueprint Medicines (BPMC)
NASDAQ:BPMC

Blueprint Medicines (BPMC) Financial Statements

523 Followers

Blueprint Medicines Financial Overview

Blueprint Medicines's market cap is currently ―. The company's EPS TTM is $-4.822; its P/E ratio is -23.27; Blueprint Medicines is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-1.29. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 96.12M$ 71.96M$ 56.57M$ 39.88M$ 63.29M
Gross Profit$ 92.92M$ 71.70M$ 53.78M$ 56.48M$ -4.47M
EBIT$ 104.39M$ -123.46M$ -129.71M$ -128.61M$ -129.04M
EBITDA$ 109.20M$ -121.93M$ -124.53M$ -122.77M$ -123.15M
Net Income Common Stockholders$ 89.14M$ -110.92M$ -130.17M$ -132.79M$ -129.56M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 647.90M$ 710.64M$ 712.98M$ 722.63M$ 822.16M
Total Assets$ 1.04B$ 1.05B$ 1.11B$ 1.11B$ 1.22B
Total Debt$ 597.93M$ 774.12M$ 774.18M$ 675.68M$ 674.93M
Net Debt$ -49.97M$ 63.48M$ 61.19M$ -46.95M$ -147.23M
Total Liabilities$ 727.79M$ 918.64M$ 902.69M$ 795.32M$ 806.07M
Stockholders Equity$ 310.69M$ 130.61M$ 202.61M$ 311.13M$ 414.30M
Cash Flow-
Free Cash Flow$ -102.62M$ -83.60M$ -110.73M$ -133.03M$ -125.55M
Operating Cash Flow$ -101.51M$ -78.93M$ -104.48M$ -130.47M$ -122.96M
Investing Cash Flow$ 77.13M$ 78.77M$ -9.59M$ 32.07M$ 172.79M
Financing Cash Flow$ 66.96M$ 15.53M$ 98.40M$ 5.30M-
Currency in USD

Blueprint Medicines Earnings and Revenue History

Blueprint Medicines Debt to Assets

Blueprint Medicines Cash Flow

Blueprint Medicines Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis